CBPE bags 22x return on IDIS exit
CBPE Capital has made a whopping 22x return on its investment in pharma company IDIS, selling it to listed trade buyer Clinigen Group.
CBPE
CBPE Capital has made a whopping 22x return on its investment in pharma company IDIS, selling it to listed trade buyer Clinigen Group.
CBPE